|
|
||||||||
, p38 MAPK, cPLA2, and 5-lipoxygenase
Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900
In a
companion paper (Vivekananda J, Smith D, and King RJ. Am J
Physiol Lung Cell Mol Physiol 281: L98-L107, 2001), we
demonstrated that tumor necrosis factor (TNF)-
inhibited the
activity of CTP:phosphocholine cytidylyltransferase (CT), the
rate-limiting enzyme in the de novo synthesis of phosphatidylcholine
(PC), and that its actions were likely exerted through a metabolite of
sphingomyelin. In this paper, we explore the signaling pathway employed
by TNF-
using C2 ceramide as a cell-penetrating
sphingolipid representative of the metabolites induced by TNF-
. We
found that in H441 cells, as reported in other cell types, cytosolic
phospholipase A2 (cPLA2) is activated by
TNF-
. We also observed that the inhibiting action of C2
ceramide on CT requires protein kinase C-
, p38 mitogen-activated protein kinase, and cPLA2. The actions of C2
ceramide on CT activity can be duplicated by adding 2 µM lysoPC to
these cells. Furthermore, we found that the effects of C2
ceramide are dependent on 5-lipoxygenase but that cyclooxygenase II is
unimportant. We hypothesize that CT activity is inhibited by the lysoPC
generated as a consequence of the activation of cPLA2 by
protein kinase C-
and p38 mitogen-activated protein kinase. The
other product of the activation of cPLA2, arachidonic acid,
is a substrate for the synthesis of leukotrienes, which raise
intracellular Ca2+ levels and complete the activation of
cPLA2.
lung injury; pulmonary surfactant; phosphatidylcholine synthesis; leukotrienes; cytidine 5'-triphosphate; protein kinase C; mitogen-activated protein kinase; cytosolic phospholipase A2
This article has been cited by other articles:
![]() |
L. Sparkman, H. Chandru, and V. Boggaram Ceramide decreases surfactant protein B gene expression via downregulation of TTF-1 DNA binding activity Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L351 - L358. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Ryan, D. M. McCoy, S. E. McGowan, R. G. Salome, and R. K. Mallampalli Alveolar sphingolipids generated in response to TNF-alpha modifies surfactant biophysical activity J Appl Physiol, January 1, 2003; 94(1): 253 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ramos, M. E. Mouedden, E. Claro, and S. Jackowski Inhibition of CTP:Phosphocholine Cytidylyltransferase by C2-Ceramide and Its Relationship to Apoptosis Mol. Pharmacol., November 1, 2002; 62(5): 1068 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Miakotina and J. M. Snyder TNF-alpha inhibits SP-A gene expression in lung epithelial cells via p38 MAPK Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L418 - L427. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vivekananda, D. Smith, and R. J. King Sphingomyelin metabolites inhibit sphingomyelin synthase and CTP:phosphocholine cytidylyltransferase Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L98 - L107. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |